HDL and Cholesterol Ester Transfer Protein (CETP).

Area of Science:

• Biochemistry
• Cardiovascular Research
• Molecular Biology

Background:

• Cholesterol ester transfer protein (CETP) is a significant target in cardiovascular disease research.
• CETP facilitates the movement of lipoproteins, influencing cholesterol transport.
• Its role in reverse cholesterol transport (RCT) and atherosclerosis is complex and debated.

Purpose of the Study:

• To elucidate the molecular mechanisms of CETP activity.
• To explore the correlation between CETP and high-density lipoprotein (HDL) metabolism.
• To review the therapeutic potential of CETP modulation for cardiovascular diseases.

Main Methods:

• Analysis of CETP's conformational flexibility and tunnel structure.
• Investigation of CETP's role in regulating cholesteryl ester (CE) concentrations in lipoproteins.
• Review of animal and cell-based experiments on CETP function.

Main Results:

• CETP activity directly impacts CE levels in HDLs, VLDLs, and LDLs.
• Inhibiting CETP may increase HDL-C and offer anti-atherosclerosis benefits.
• Contradictory findings exist, with some studies suggesting CETP can mitigate atherosclerosis via RCT.

Conclusions:

• CETP's complex role in atherosclerosis requires further investigation.
• CETP inhibitors aim to enhance efficacy and reduce side effects.
• CETP agonists also show promise in resisting atherosclerosis, indicating dual therapeutic strategies.